Shenzhen New Industries Biomedical Financial Flexibility Index
Shenzhen New Industries Biomedical financial flexibility index. Shenzhen New Industries Biomedical (300832) has a Financial Flexibility Index of 0.78x as of September 2025. Free cash flow of CN¥651.99 Million (operating CF CN¥606.21 Million minus capex CN¥45.78 Million) represents 1% of total liabilities (CN¥831.98 Million). See 300832 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Shenzhen New Industries Biomedical (2012–2024)
Financial flexibility index of Shenzhen New Industries Biomedical from 2012 to 2024. Historical Financial Flexibility Index trend for Shenzhen New Industries Biomedical across 13 annual periods. Check cash flow quality index of Shenzhen New Industries Biomedical to evaluate the quality of earnings relative to operating cash generation.
Shenzhen New Industries Biomedical Financial Flexibility Index by Year (2012–2024)
Shenzhen New Industries Biomedical financial flexibility index by year from 2012 to 2024. Year-by-year free cash flow to debt coverage for Shenzhen New Industries Biomedical. For the full cash flow conversion analysis, see Shenzhen New Industries Biomedical (300832) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.72x | CN¥1.80 Billion | CN¥1.36 Billion | CN¥1.04 Billion | ▼ -32.9% |
| 2023 | 2.57x | CN¥1.74 Billion | CN¥1.42 Billion | CN¥678.09 Million | ▲ +15.6% |
| 2022 | 2.22x | CN¥1.37 Billion | CN¥962.39 Million | CN¥615.06 Million | ▲ +4.1% |
| 2021 | 2.13x | CN¥1.12 Billion | CN¥773.22 Million | CN¥523.51 Million | ▼ -13.2% |
| 2020 | 2.46x | CN¥1.23 Billion | CN¥976.65 Million | CN¥501.49 Million | ▼ -32.4% |
| 2019 | 3.63x | CN¥1.16 Billion | CN¥831.73 Million | CN¥318.92 Million | ▲ +1.1% |
| 2018 | 3.59x | CN¥986.83 Million | CN¥701.97 Million | CN¥274.52 Million | ▲ +28.2% |
| 2017 | 2.80x | CN¥701.24 Million | CN¥524.73 Million | CN¥250.00 Million | ▼ -4.0% |
| 2016 | 2.92x | CN¥542.84 Million | CN¥486.81 Million | CN¥185.75 Million | ▼ -14.2% |
| 2015 | 3.40x | CN¥425.42 Million | CN¥305.93 Million | CN¥124.94 Million | ▲ +20.0% |
| 2014 | 2.84x | CN¥382.68 Million | CN¥253.47 Million | CN¥134.92 Million | ▲ +63.5% |
| 2013 | 1.74x | CN¥281.28 Million | CN¥138.33 Million | CN¥162.12 Million | ▲ +65.4% |
| 2012 | 1.05x | CN¥68.10 Million | CN¥55.80 Million | CN¥64.93 Million | — |